Behavioral phenomenology in Alzheimer's disease, frontotemporal dementia, and late-life depression: A retrospective analysis

Journal of Geriatric Psychiatry and Neurology

Volumn 10, Issue 2, 1997, Pages 67-74

  Swartz, J Randolph ^a,b   Miller, Bruce L ^a,b   Lesser, Ira M ^a,b   Booth, Ruth ^a   Darby, Amy ^a   Wohl, Marcy ^a   Benson, D Frank ^b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; DEMENTIA; DEPRESSION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISCRIMINANT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; NEUROPSYCHIATRY; PHENOMENOLOGY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SYMPTOMATOLOGY;

EID: 0030754980     PISSN: 08919887     EISSN: None     Source Type: Journal    
DOI: 10.1177/089198879701000206     Document Type: Article

References (69)

1. Greenwald BS, Kramer-Ginsberg E, Marin DB, et al. Dementia with coexistent major depression. Am J Psychiatry 1989; 146:1472-1478.
2. Mendez MF, Selwood A, Mastri AF, Frey WH. Pick's disease versus Alzheimer's disease: a comparison of clinical characteristics. Neurology 1993; 43:289-292.
3. McGuire MH, Rabins PV. Mood Disorders. In: Coffey CE, Cummings JL, eds. Textbook of geriatric neuropsychiatry. 1st Ed. Washington, DC: American Psychiatric Press Inc., 1994:243-260.
4. Kumar A, Schapiro MB, Haxby JV, et al. Cerebral metabolic and cognitive studies in dementia with frontal lobe behavioral features. J Psychiatr Res 1990; 24:97-109.
5. Miller BL, Cummings JL, Villanueva-Meyer J, et al. Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology 1991; 41:1374-1382.
6. Cummings JL, Duchen LW. Kluver-Bucy syndrome in Pick disease: clinical and pathological correlations. Neurology 1981; 31:1415-1422.
7. Wragg RE, Jeste DV. Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry 1989; 146:577-587.
8. Cummings JL, Victoroff JI. Noncognitive neuropsychiatric syndromes in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol 1990; 3:140-158.
9. Wild KV, Kaye JA, Oken BS. Early noncognitive change in Alzheimer's disease and healthy aging. J Geriatr Psychiatry Neurol 1994; 7:199-205.
10. Alzheimer A. Uber eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie und Psychisch-Gerichtlich Medicin 1907; 64:146-148.
11. 99mTc-HM-PAO in the investigation of dementia. J Neurol Neurosurg Psychiatry 1987; 50:1101-1109.
12. Perani D, Di Piero V, Vallar G, et al. Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. J Nucl Med 1988; 29:1507-1514.
13. Holman BL, Johnson KA, Gerada B, et al. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. J Nucl Med 1992; 33:181-185.
14. Pick A. Uber die Beziehungen der senile Hirnatrophie zur Aphasie. Pragmatische Medizinische Wehnschrift 1892; 17: 165-167.
15. Sjogren T, Sjogren H, Lindgren AGH. Morbus Alzheimer and morbus Pick. A genetic, clinical, and patho-anatomical study. Acta Psychiatr Neurol Scand 1952; 82(suppl):1-152.
16. Constantinidis J, Richard J, Tissot R. Pick's disease: histological and clinical correlations. Eur Neurol 1974; 11:208-217.
17. Filley CM, Kleinschmidt-DeMasters BK, Gross KF. Non-Alzheimer fronto-temporal degenerative dementia. A neurobehavioral and pathological study. Clin Neuropathol 1994; 13:109-116.
18. Alexopoulos GS, Meyers BS, Young RC, et al. Brain changes in geriatric depression. Int J Geriatr Psychiatry 1988; 3: 157-161.
19. Coffey CE, Figiel GS, Djang WT, Weiner RD. Subcortical hyperintensity on magnetic resonance imaging: a comparison of normal and depressed elderly subjects. Am J Psychiatry 1990; 147:187-189.
20. Lesser IM, Miller BM, Boone KB, et al. Brain injury and cognitive function in late-onset psychotic depression. J Neuropsychiatry Clin Neurosci 1991; 3:33-40.
21. Upadhyaya AK, Abou-Saleh MT, Wilson K, et al. A study of depression in old age using single-photon emission computerised tomography. Br J Psychol 1990; 157 (suppl 9):76-81.
22. Zubenko GS, Sullivan P, Nelson JP, et al. Brain imaging abnormalities in mental disorders of late-life. Arch Neurol 1990; 47:1107-1111.
23. Rabins PV, Pearlson GD, Aylward E, et al. Cortical magnetic resonance imaging changes in elderly inpatients with major depression. Am J Psychiatry 1991; 148: 617-620.
24. Coffey CE, Wilkinson WE, Weiner RD, et al. Quantitative cerebral anatomy in depression: a controlled magnetic resonance imaging study. Arch Gen Psychiatry 1993; 50:7-16.
25. Lesser IM, Mena I, Boone KB, et al. Reduction of cerebral blood flow in older depressed patients. Arch Gen Psychiatry 1994; 51:677-686.
26. Sparks DL, Markesbery WR. Altered serotonergic and cholinergic synaptic markers in Pick's Disease. Arch Neurol 1991; 48:796-799.
27. Bird TD, Stranahan S, Sumi SM, Raskind M. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups. Ann Neurol 1983; 14:284-293.
28. Bowen DM, Allen SJ, Benton JS, et al. Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. J Neurochem 1983; 41:266-272.
29. Dewar D, Graham DI, McCulloch J. 5HT-2 receptors in dementia of the Alzheimer type: a quantitative autoradiographic study of frontal cortex and hippocampus. J Neural Transm Park Dis Dement Sect 1990; 2:129-137.
30. Halliday GM, McCann HL, Pamphlett R, et al. Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation. Acta Neuropathol (Berl) 1992; 84:638-650.
31. Tejani-Butt SM, Yang J, Pawllyk AC. Altered serotonin transport sites in Alzheimer's disease raphe and hippocampus. Neuroreport 1995; 6:1207-1210.
32. Schildkraut JJ. Neuropsychopharmacology and the affective disorders. N Engl J Med 1969; 281:302-308.
33. Maas JW. Biogenic amines and depression. Arch Gen Psychiatry 1975; 32:1357-1361.
34. Richelson E. Biological basis of depression and therapeutic relevance. J Clin Psychiatry 1991; 52(suppl 6):4-10.
35. Janowsky DS, El Yousef MK, Dario JM. A cholinergic adrenergic hypothesis of mania and depression. Lancet 1972; 1: 1385-1386.
36. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198.
37. Spitzer RL, Williams JB. Structured clinical interview for DSM-III-R. New York: New York State Psychiatric Institute, 1986.
38. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Psychol 1967; 6:278-296.
39. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: a report of the NINCDS-ADRA Work-group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944.
40. Brun A, Englund B, Gustafson L, et al. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994; 57:416-418.
41. Wing JK, Babor T, Brugha T, et al. SCAN: Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 1990; 47:589-593.
42. World Health Organization. Schedules for Clinical Assessment in Neuropsychiatry (SCAN). Geneva: World Health Organization, 1992.
43. Janca A, Ustun TB, Sartorius N. New versions of World Health Organization instruments for the assessment of mental disorders. Acta Psychiatr Scand 1994; 90:73-83.
44. SAS Institute Inc. SAS/STAT user's guide, Release 6.03 Edition. Cary, NC: SAS Institute Inc, 1988.
45. BMDP Statistical Software, Inc. BMDP statistical software manual. Berkeley, CA: University of California Press, 1990.
46. Lachenbruch PA. An almost unbiased method of obtaining confidence intervals for the probability of misclassification in discriminant analysis. Biometrics 1967; 23:639-645.
47. Rovner BW, Broadhead J, Spencer M, et al. Depression and Alzheimer's disease. Am J Psychiatry 1989; 146:350-353.
48. Anderson IM, Harborne G. Serotonin and depression in frontal lobe dementia. Am J Psychiatry 1995; 152:645.
49. Gonzalez MP, Lopez OL, Sudilovsky A, et al. Differences in neuropsychiatric profile in Alzheimer's disease and non-Alzheimer disease dementias. New Research Program and Abstracts. American Psychiatric Association Annual Meeting, 1995: 61-62.
50. Cummings JL, Miller BL, Hill MA, Neshkes R. Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer type. Arch Neurol 1987; 44:389-393.
51. Binetti G, Bianchetti A, Padovani A, et al. Delusions in Alzheimer's disease and multi-infarct dementia. Acta Neurol Scand 1993; 88:5-9.
52. Holden NL. Late paraphrenia or the paraphrenias? a descriptive study with a 10 year follow-up. Br J Psychiatry 1987; 150:635-639.
53. Lesser IM, Miller BL, Boone KB, et al. Psychosis as the first manifestation of degenerative dementia. Bull Clin Neurosci 1989; 54:59-63.
54. Tonkonogy JM, Smith TW, Barreira PJ. Obsessive-compulsive disorders in Pick's disease. J Neuropsychiatry Clin Neurosci 1994; 6:176-180.
55. Miller BL, Darby AL, Swartz JR, et al. Dietary changes, compulsions and sexual behavior in frontotemporal degeneration. Dementia 1995; 6:195-199.
56. Cummings JL, Benson DF, Hill MA, Read S. Aphasia in dementia of the Alzheimer type. Neurology 1985; 35:394-397.
57. Ross ED. The aprosodias. Arch Neurol 1981; 38:561-569.
58. Miller BL, Chang L, Mena I, et al. Progressive right frontotemporal degeneration: clinical, neuropsychological and SPECT characteristics. Dementia 1993; 4:204-213.
59. Blumer D, Benson DF. Personality changes with frontal and temporal lobe lesions. In: Benson DF, Blumer D, eds. Psychiatric aspects of neurological disease. New York: Grune & Stratton, 1975:151-170.
60. Eslinger PJ, Damasio AR. Severe disturbance of higher cognition after bilateral frontal lobe ablation. Neurology 1985; 35:1731-1741.
61. Asberg M, Traskman L, Thoren P. 5-HIAA in the cerebrospinal fluid; a biochemical suicide predictor? Arch Gen Psychiatry 1976; 33:1193-1197.
62. Linnoila M, Virkkunen M, Scheinin M, et al. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci 1983; 33:2609-2614.
63. Brown GL, Ebert MH, Goyer PF, et al. Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am J Psychiatry 1982; 139:741-746.
64. Miller BL, Itti L, Li J, et al. Atrophy-corrected cerebral blood flow in fronto-temporal dementia. Facts Res Gerontol 1995; (suppl):93-103.
65. Mathew RJ, Meyer JS, Francis DJ, et al. Cerebral blood flow in depression. Am J Psychiatry 1980; 137:1449-1450.
66. Robinson RG, Szetela B. Mood change following left hemispheric brain injury. Ann Neurol 1981; 9:447-453.
67. Baxter LR, Schwartz JM, Phelps ME, et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989; 46:243-250.
68. Martinot JL, Hardy P, Feline A, et al. Left prefrontal glucose hypometabolism in the depressed state: a confirmation. Am J Psychiatry 1990; 147:1313-1317.
69. Leonard BE. Serotonin receptors-where are they going? Int Clin Psychopharmacol 1994; 9(suppl 1):7-17.